Clinical Study on Anti-tumor Effect Induced by Activated Primary Natural Killer（NK）Cells
Clinical trial NCT03634501 · UNKNOWN
Trial details
- NCT number
- NCT03634501
- Sponsor
- Xuanwu Hospital, Beijing
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-26
- Primary completion
- 2021-09-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.